Anti-JC virus antibodies: implications for PML risk stratification.
Gorelik L, Lerner M, Bixler S, Crossman M, Schlain B, Simon K, Pace A, Cheung A, Chen LL, Berman M, Zein F, Wilson E, Yednock T, Sandrock A, Goelz SE, Subramanyam M.
Gorelik L, et al. Among authors: goelz se.
Ann Neurol. 2010 Sep;68(3):295-303. doi: 10.1002/ana.22128.
Ann Neurol. 2010.
PMID: 20737510